Search

everythinglearnresearchcommunity

for

Search:↓

Aging reduces skin cell renewal and defense against germs due to TGFbeta, but blocking TGFbeta could help restore these functions.

Removing STAT5 from 3D-cultured human skin cells reduces their ability to grow hair.

Kaempferol helps skin stem cells grow and may improve skin thickness due to its 3-OH group.

The model can effectively test gene functions and drug responses in human skin.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Dermatologists helped identify COVID-19 through skin symptoms and managed skin issues during the pandemic, but more high-quality research is needed.

Hydroxypinacolone retinoate is a potent anti-aging ingredient for skin that is more effective and less irritating than other forms of retinoids.

In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

Older hair follicle stem cells have a reduced ability to renew themselves, leading to more hair loss.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Activating Nrf2 helps wounds heal faster by increasing hair follicle stem cells.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Three compounds from Dadap leaves may help treat hair loss.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.